October 26, 2016 5:56 AM ET

Life Sciences Tools and Services

Company Overview of WuXi PharmaTech (Cayman) Inc.

Company Overview

Wuxi PharmaTech (Cayman) Inc. operates as a pharmaceutical, biotechnology, and medical device research and development services company in China and the United States. It operates through two segments, Laboratory Services and Manufacturing Services. The Laboratory Services segment offers services for small molecules, such as synthetic chemistry, biology, medicinal chemistry, DMPK/ADME, formulation, analytical chemistry, toxicology, clinical development, bioanalytical, genomics, bioinformatics, research reagent production, and clinical services; services for discovery and development of biologics; and laboratory services, including testing services for biologics, medical devices, and combinat...

288 Fute Zhong Road

China (Shanghai) Pilot Free Trade Zone

Shanghai,  200131


Founded in 2000

8,837 Employees


86 21 5046 1111

Key Executives for WuXi PharmaTech (Cayman) Inc.

Co-Founder, Chairman, Chief Executive Officer, Member of Strategy & Finance Committee and Member of Corporate Governance & Nominations Committee
Age: 49
Co-Founder, Head of Corporate Human Resources, Senior Vice President of Operations and Director
Age: 49
Founder, Senior Vice President of Operations and Director
Age: 46
Chief Financial Officer and Chief Investment Officer
Age: 53
Chief Operating Officer and Executive Vice President
Compensation as of Fiscal Year 2016.

WuXi PharmaTech (Cayman) Inc. Key Developments

Wuxi AppTec Opens Branch in South Korea

WuXi AppTec (China) has opened a branch in Seoul, South Korea. The company aims to provide customised services to clients within South Korea, and to bring South Korean healthcare products to the Chinese market and other countries.

WuXi PharmaTech Mulls IPO For Its Biologics Subsidiary

WuXi PharmaTech (Cayman) Inc. (NYSE:WX) is planning to conduct a Hong Kong IPO of its biologics subsidiary, according to a Bloomberg report.

WuXi PharmaTech (Cayman) Inc.(NYSE:WX) dropped from Russell Global Index

WuXi PharmaTech (Cayman) Inc.(NYSE:WX) dropped from Russell Global Index

Recent Private Companies Transactions

April 15, 2016
Crelux GmbH
Private Placement
December 2, 2015

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact WuXi PharmaTech (Cayman) Inc., please visit www.wuxiapptec.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.